Comments on: Ocaliva poses enrolment obstacle in liver disease clinical trials /analyst-comment/ocaliva-poses-enrolment-obstacle-in-liver-disease-clinical-trials/ The leading site for news and procurement in the pharmaceutical industry Thu, 24 Nov 2022 12:15:58 +0000 hourly 1 https://wordpress.org/?v=6.6.1